[go: up one dir, main page]

FI954898A7 - Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina - Google Patents

Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina Download PDF

Info

Publication number
FI954898A7
FI954898A7 FI954898A FI954898A FI954898A7 FI 954898 A7 FI954898 A7 FI 954898A7 FI 954898 A FI954898 A FI 954898A FI 954898 A FI954898 A FI 954898A FI 954898 A7 FI954898 A7 FI 954898A7
Authority
FI
Finland
Prior art keywords
preparation
water
antitumor agents
camptothecin derivatives
soluble camptothecin
Prior art date
Application number
FI954898A
Other languages
English (en)
Swedish (sv)
Other versions
FI954898A0 (fi
Inventor
Angelo Bedeschi
Franco Zarini
Walter Cabri
Ilaria Candiani
Sergio Penco
Laura Capolongo
Original Assignee
Pharmacia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Spa filed Critical Pharmacia Spa
Publication of FI954898A0 publication Critical patent/FI954898A0/fi
Publication of FI954898A7 publication Critical patent/FI954898A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI954898A 1994-02-16 1995-10-13 Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina FI954898A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9402934A GB9402934D0 (en) 1994-02-16 1994-02-16 Camptothecin derivatives and process for their preparation
PCT/EP1995/000393 WO1995022549A1 (en) 1994-02-16 1995-02-03 Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents

Publications (2)

Publication Number Publication Date
FI954898A0 FI954898A0 (fi) 1995-10-13
FI954898A7 true FI954898A7 (fi) 1995-10-13

Family

ID=10750430

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954898A FI954898A7 (fi) 1994-02-16 1995-10-13 Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina

Country Status (20)

Country Link
US (2) US5602141A (fi)
EP (1) EP0694035B1 (fi)
JP (1) JPH08509244A (fi)
KR (1) KR960701878A (fi)
CN (1) CN1123548A (fi)
AT (1) ATE220681T1 (fi)
AU (1) AU681941B2 (fi)
CA (1) CA2158855C (fi)
DE (1) DE69527400T2 (fi)
ES (1) ES2180625T3 (fi)
FI (1) FI954898A7 (fi)
GB (1) GB9402934D0 (fi)
HU (1) HUT73423A (fi)
IL (1) IL112622A (fi)
MX (1) MX9504287A (fi)
NO (1) NO954072L (fi)
NZ (1) NZ279813A (fi)
PL (1) PL311122A1 (fi)
WO (1) WO1995022549A1 (fi)
ZA (1) ZA951227B (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9319944D0 (en) * 1993-09-28 1993-11-17 Erba Carlo Spa Process for the preparation of 9-amino camptothecin
US5880131A (en) * 1993-10-20 1999-03-09 Enzon, Inc. High molecular weight polymer-based prodrugs
US5965566A (en) * 1993-10-20 1999-10-12 Enzon, Inc. High molecular weight polymer-based prodrugs
GB9402934D0 (en) * 1994-02-16 1994-04-06 Erba Carlo Spa Camptothecin derivatives and process for their preparation
GB9410388D0 (en) * 1994-05-24 1994-07-13 Erba Carlo Spa Method for the preparation of 9-amino camptothecin
GB9510716D0 (en) * 1995-05-26 1995-07-19 Pharmacia Spa Substituted camptothecin derivatives and process for their preparation
US6096336A (en) * 1996-01-30 2000-08-01 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
GB9601779D0 (en) * 1996-01-30 1996-04-03 Pharmacia Spa 9, 10 Disubstituted camptothecin derivatives
GB9702807D0 (en) 1997-02-12 1997-04-02 Pharmacia & Upjohn Spa Alkynyl-substituted camptothecins and process for their preparation
GB9715821D0 (en) * 1997-07-25 1997-10-01 Pharmacia & Upjohn Spa Amidino-camptothecin derivatives
US6043367A (en) * 1998-09-30 2000-03-28 Roffler; Steve Proactive antitumor compounds
US6228855B1 (en) 1999-08-03 2001-05-08 The Stehlin Foundation For Cancer Research Aromatic esters of camptothecins and methods to treat cancers
US6352996B1 (en) 1999-08-03 2002-03-05 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
WO2001024763A2 (en) 1999-10-01 2001-04-12 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AU2002356720B2 (en) 2001-11-30 2009-01-29 Chugai Seiyaku Kabushiki Kaisha Hexacyclic compounds
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
CZ299329B6 (cs) * 2003-08-26 2008-06-18 Pliva-Lachema A.S. Zpusob výroby 7-ethyl-10-[ 4-(1-piperidino)-1-piperidino]karbonyloxykamptothecinu
CZ299593B6 (cs) * 2003-12-16 2008-09-10 Pliva-Lachema A. S. Zpusob výroby 7-ethyl-10-hydroxykamptothecinu
BRPI0509732A (pt) 2004-04-09 2007-09-25 Chugai Pharmaceutical Co Ltd pró-fármaco solúvel em água, composição farmacêutica, agente terapêutico, agente antifungo e uso do referido pró-fármaco
TW200744603A (en) 2005-08-22 2007-12-16 Chugai Pharmaceutical Co Ltd Novel anticancer concomitant drug
JP5126900B2 (ja) * 2009-02-24 2013-01-23 株式会社渡辺オイスター研究所 カキ肉エキス顆粒の製造方法。
CN101555250B (zh) * 2009-05-19 2011-05-18 重庆泰濠制药有限公司 盐酸拓扑替康的制备方法
US20240269309A1 (en) * 2021-05-27 2024-08-15 Zymeworks Inc. Camptothecin analogues, conjugates and methods of use
CN117547535A (zh) 2021-10-15 2024-02-13 昆山新蕴达生物科技有限公司 包含抗肿瘤药物的组合物及其制备方法和用途
KR20240162575A (ko) * 2022-03-25 2024-11-15 자임워크스 비씨 인코포레이티드 엽산 수용체 알파를 표적화하는 항체-약물 접합체 및 사용 방법
CN119948062A (zh) * 2022-10-19 2025-05-06 酵活英属哥伦比亚有限公司 靶向napi2b的抗体-药物缀合物及其使用方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399276A (en) * 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
JPS6019790A (ja) * 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4981968A (en) * 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
US5364858A (en) * 1987-03-31 1994-11-15 Research Triangle Institute Camptothecin analogs as potent inhibitors of topoisomerase I
US5227380A (en) * 1987-03-31 1993-07-13 Research Triangle Institute Pharmaceutical compositions and methods employing camptothecins
US5180722A (en) * 1987-04-14 1993-01-19 Research Triangle Institute 10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs
US4943579A (en) * 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JPH0615547B2 (ja) * 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
WO1991004260A2 (en) * 1989-09-15 1991-04-04 Research Triangle Institute 10,11-methylenedioxy-20(rs)-camptothecin and 10,11-methylenedioxy-20(s)-camptothecin analogs
ATE211142T1 (de) * 1989-09-15 2002-01-15 Res Triangle Inst Verfahren zur herstellung von 10,11-methylendioxy-20(rs)-camptothecin und 10,11-methylendioxy-20(s)-camptothecin-analog
AU664830B2 (en) * 1990-09-28 1995-12-07 Smithkline Beecham Corporation Water soluble camptothecin analogues, processes and methods
US5162532A (en) * 1990-12-20 1992-11-10 North Carolina State University Intermediates and method of making camptothecin and camptothecin analogs
US5342947A (en) * 1992-10-09 1994-08-30 Glaxo Inc. Preparation of water soluble camptothecin derivatives
GB9402934D0 (en) * 1994-02-16 1994-04-06 Erba Carlo Spa Camptothecin derivatives and process for their preparation

Also Published As

Publication number Publication date
HUT73423A (en) 1996-07-29
DE69527400T2 (de) 2003-03-06
EP0694035B1 (en) 2002-07-17
FI954898A0 (fi) 1995-10-13
PL311122A1 (en) 1996-02-05
NZ279813A (en) 1996-10-28
IL112622A (en) 1997-09-30
DE69527400D1 (de) 2002-08-22
EP0694035A1 (en) 1996-01-31
AU1705695A (en) 1995-09-04
HU9503273D0 (en) 1996-01-29
NO954072L (no) 1995-12-11
CN1123548A (zh) 1996-05-29
KR960701878A (ko) 1996-03-28
ZA951227B (en) 1996-01-19
ES2180625T3 (es) 2003-02-16
MX9504287A (es) 1997-05-31
WO1995022549A1 (en) 1995-08-24
AU681941B2 (en) 1997-09-11
JPH08509244A (ja) 1996-10-01
US5801167A (en) 1998-09-01
IL112622A0 (en) 1995-05-26
CA2158855A1 (en) 1995-08-24
CA2158855C (en) 2006-01-31
ATE220681T1 (de) 2002-08-15
GB9402934D0 (en) 1994-04-06
US5602141A (en) 1997-02-11
NO954072D0 (no) 1995-10-13

Similar Documents

Publication Publication Date Title
FI954898A7 (fi) Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina
EE03231B1 (et) Tetratsüklilised derivaadid, nende valmistamismeetod ja kasutamine
HUP0104167A3 (en) 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
FI955913A0 (fi) Uudet erytromysiinijohdannaiset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
EE03568B1 (et) Bensimidasooli derivaadid, nende valmistamismeetod ja kasutamine
FI965020A7 (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
HU9602305D0 (en) 4-heterocyclyl-substituted quinazoline derivatives, process for their preparation and their use as anti-cancer agents
IL147923A0 (en) 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
IL147925A0 (en) 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
IL142371A0 (en) 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
FI931384A7 (fi) Vesiliukoisia kamptotekiinianalogeja, prosesseja ja menetelmiä
HUP0202492A3 (en) Arylmethyl-carbonylamino-thiazole derivatives process for their preparation and their use as antitumor agents
EE03482B1 (et) Kinasoliiniderivaadid, nende valmistamismeetod ja kasutamine
FI955235L (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
FI951468A7 (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
HUP0201225A3 (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agent and process for their preparation
EE04721B1 (et) Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
CY2013003I1 (el) Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
EE9800302A (et) Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat
EE9800265A (et) Erütromütsiini derivaadid, nende valmistamismeetod ja kasutamine ravimitena
EE9600172A (et) Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid
EE9900112A (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
HUP9900987A3 (en) Camptothecin derivatives process for their preparation, use thereof as antitumor agents and pharmaceutical compositions containing them
EE9900155A (et) 1H-pürido[3,4-b]indool-4-karboksamiidi derivaadid, nende valmistamismeetod ja kasutamine raviks
EE9800145A (et) Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACIA & UPJOHN S.P.A.

FD Application lapsed